Research indicates that prior authorizations for drugs take physician practices and pharmacies 15 to 64 minutes to complete ...
ADC targeting both PSMA and STEAP1 with a topoisomerase payload showed a 15-month PFS signal in heavily pretreated prostate ...
The FDA recently approved ensitrelvir (Xocova; Shionogi), an anti–SARS-CoV-2 oral drug for post-exposure prophylaxis (PEP) of COVID-19, for adults and adolescents 12 years of age and older. 1 The ...
Two nights before the data were announced, “transformative” was the word used to describe the results for RASolute 302 ...
Adam Kittai, MD, breaks down the evolving landscape of CLL sequencing—from venetoclax retreatment to triplet regimens. As he ...
Higher rates of adverse events offset the positive survival results in an area of great unmet need. For decades, the standard ...
At a median follow-up of 28.3 months, Mosun-Pola continued to demonstrate superior progression-free survival (PFS) over R-GemOx across the full trial population (HR, 0.41; 95% CI, 0.28-0.60). The ...
While lifestyle alterations have been previously recommended to control potassium levels for some patients with hyperkalemia, ...
Overall, ATS 2026 covered a variety of different areas in pulmonary and thoracic health, highlighting areas that require more ...
Fee-for-service beneficiaries had higher BGP use than Medicare Advantage (25.8% vs 24.6%; AOR 1.08), indicating payer ...
Intraoperative cesium-131 tile-based radiation therapy (TBRT) with GammaTile significantly improved local control, surgical bed recurrence-free survival (SB-RFS), and overall surv ...
Fragmented subspecialty care and underbuilt survivorship pathways risk overwhelming primary care as the survivor population ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results